Job offer from October 07, 2022
The Max Planck Institute of Immunobiology and Epigenetics in Freiburg, Germany is an interdisciplinary research institution that conducts basic research in key areas of modern biology. The future scientific orientation of the Institute will be focused on chromatin and epigenetic research and address mechanistic principles of epigenetic regulation at a very broad scale.
The Institute currently consists of four senior groups (Max Planck Directors Akhtar, Boehm, Cissé and Jenuwein) and 5 independent junior groups who together do research in the regulation of dosage compensation, epigenetic inheritance, evolution of the adaptive immune system, control of cell type identities, single-molecule analysis of transient biomolecular interactions in living cells and heterochromatin formation. We now have openings for three independent junior groups that should ideally complement some of these ongoing research lines. In particular, we are looking for candidates who work on the molecular mechanisms of chromatin structure, mobile RNA function, genome architecture, chromatin response to metabolic and/or environmental changes, developmental epigenetics across species and epigenetic dysfunction in disease.
The independent junior group leader positions (m/f/d) will be available from spring 2023 and are initially funded for five years with the possibility of extension for up to nine years. They all have an attractive package that, in addition to the group leader position, also covers 2 PhD students, 1 research assistant and appropriate consumables. As an independent junior group leader, there is also access to state-of-the-art infrastructures (from high-end single molecule imaging, automated genome-wide expression and ChIP profiling, proteomics and metabolites biochemistry to animal facilities including a new mouse house). In addition, independent junior group leaders participate in the international IMPRS-IEM PhD program that is offered by the institute.
We are looking for highly motivated scientists with excellent postdoctoral experience that is documented by several high-profile first author publications. The proposed research program is expected to be innovative and to address a key question in modern epigenetics. The use of mouse models is highly encouraged.
The Institute is located in Freiburg im Breisgau, a dynamic and green university city with a 900-year history. The city in the trinational border region (Germany, Switzerland, and France) impresses newcomers with its high quality of life and international flair. Freiburg ranks third on Lonely Planet’s “Best in Travel 2022” list of the top ten city destinations in the world and according to The Guardian (September 2022) belongs to the ten best “European city breaks with a difference”.
Our institute offers an international research environment with outstanding infrastructure facilities and a positive working atmosphere that places a high value on work-life balance.
- Salary according to the regulations of the TVöD Bund
- Social benefits in line with public service (VBL)
- Additional performance-related remuneration component
- Professional training and development opportunities
- Good public transport connections and subsidy for job ticket
- Challenging work in a modern working environment
- Family-friendly offers (affiliated day care center at the institute, parent-child room, breastfeeding room)
We value and promote diversity, inclusion and equal opportunities, so we welcome applications from all backgrounds. We particularly welcome applications from severely disabled people. We would also like to increase the proportion of women in areas where they are underrepresented and therefore expressly encourage women to apply.
Please apply with your complete application documents as one single PDF file (cover letter including a three-page research statement, describing past, present and future research activities, CV and up to three letters of support) to the Managing Director: firstname.lastname@example.org.
The application deadline is December 31, 2022.
Max Planck Institute for Immunobiology and Epigenetics